Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the relationship between magnesium sulphate administration and levels of S100B protein in serum of patients undergoing supratentorial brain parenchymal resection.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sara Varea
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Male and females older than 18 years.

• Undergoing supratentorial parenchyma resection surgery.

• Capable of collaborate on probes and explorations included in the study.

• Signature the written informed consent form.

Exclusion Criteria:

• Life expectancy less than 12 months due to the suspected histological type of tumour.

• Hypothalamic-pituitary axis illness.

• Presence of Melanoma previously.

• Glomerular filtration rate less than 60 mL/min.

• Thyroid or parathyroid glands pathology.

• Myasthenia gravis.

• Respiratory depression.

• Pregnancy or breastfeeding.